Archive: March 2015
Feature Article
Key Statistical Concepts in Cancer Research
Qian Shi, PhD, and Daniel J. Sargent, PhD
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Qian Shi, PhD, and Daniel J. Sargent, PhD The authors are affiliated with […]
Feature Article
Review of Treatment Options for Oligometastatic Non–Small Cell Lung Cancer
Michael R. Folkert, MD, PhD, and Robert Timmerman, MD
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Michael R. Folkert, MD, PhD, and Robert Timmerman, MD The authors are affiliated […]
Advances in Hematology
The Shifting Paradigm for Transfusion of Red Blood Cells
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Jeffrey L. Carson, MD, Richard C. Reynolds Professor of Medicine, Chief, Division of General Internal Medicine, Rutgers Robert […]
Advances in LLM
Rituximab Maintenance in Follicular Lymphoma
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Paul M. Barr, MD, Assistant Professor, Department of Medicine, University of Rochester, Medical Center, Rochester, New York […]
Advances in Drug Development
The National Cancer Institute’s Experimental Therapeutics Clinical Trials Network
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 S. Percy Ivy, MD, Associate Chief, Cancer Therapy Evaluation Program, Investigational Drug Branch, Division of Cancer Treatment […]
Advances in Oncology
The Role of Third-Generation Epithelial Growth Factor Receptor Inhibitors in Non–Small Cell Lung Cancer
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Lecia V. Sequist, MD, MPH, Associate Professor, Harvard Medical School, Boston, Massachusetts H&O How did […]
Hepatocellular Carcinoma: Current Questions and Future Directions
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Robert G. Gish, MD, Clinical Professor of Medicine (Consultant), Stanford Hospital and Medical Center, Stanford, California, Clinical […]
Counterpoints
Counterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Multiple myeloma is an incurable disease, and patients who respond to treatment eventually […]
Hem/Onc News
Hem/Onc News
Devon Schuyler, Kathryn Turner PhD
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 FDA Approves Palbociclib for Breast Cancer Palbociclib (Ibrance, Pfizer) has received accelerated approval […]
Letter From the Editor
Letter From the Editor
Bruce D. Cheson, MD
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Lies and Truth If you tell the truth, you don’t have to remember […]